10x Genomics, Inc. Accounts Payable
10x Genomics, Inc. (TXG) had Accounts Payable of $20.69 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-07
- 2026-06-30: Accounts Payable, Current $20.69M.
- 2026-03-31: Accounts Payable, Current $17.43M.
- 2025-12-31: Accounts Payable, Current $12.73M.
- 2025-09-30: Accounts Payable, Current $18.07M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $20.69M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $17.43M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $12.73M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $18.07M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $15.94M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $10.07M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $12.91M 10-K · filed 2026-02-13 |
| 2024-09-30 | $26.21M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $21.25M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $20.22M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $15.74M 10-K · filed 2025-02-13 |
| 2023-09-30 | $18.84M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $23.12M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $29.32M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $21.60M 10-K · filed 2024-02-15 |
| 2022-09-30 | $21.59M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $26.73M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $18.96M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $17.35M 10-K · filed 2023-02-16 |
| 2021-09-30 | $17.04M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $16.18M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $15.58M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $4.71M 10-K · filed 2022-02-18 |
| 2020-09-30 | $9.49M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $9.92M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $13.51M 10-Q · filed 2020-05-12 |
| 2019-12-31 | $13.03M 10-K · filed 2021-02-26 |
| 2019-09-30 | $11.96M 10-Q · filed 2019-11-12 |
| 2018-12-31 | $8.79M 10-K · filed 2020-02-27 |